Literature DB >> 15954778

Immobilization of rhodium complexes at thiolate monolayers on gold surfaces: catalytic and structural studies.

Thomas Belser1, Meike Stöhr, Andreas Pfaltz.   

Abstract

Chiral rhodium-diphosphine complexes have been incorporated into self-assembled thiolate monolayers (SAMs) on gold colloids. Catalysts of this type are of interest because they combine properties of homogeneous and heterogeneous systems. In addition, it should be possible to influence the catalytic properties of the metal center by the neighboring thiolate molecules. Colloids with a diameter of ca. 3 nm, coated with a mixed monolayer of n-octanethiolates and thiolates with chiral rhodium-PYRPHOS end groups, were studied as hydrogenation catalysts. With methyl alpha-acetamido-cinnamate as substrate, virtually the same enantioselectivities (up to 93% ee) and full conversion were obtained as with the corresponding homogeneous [Rh(COD)(PYRPHOS)]BAr(F) catalyst. The colloids were easily recovered by filtration and reused as catalysts three times without loss of enantioselectivity. STM studies of analogous SAMs on Au(111) gave a detailed picture of the structure and dynamics of mixed monolayers of this type. The STM images showed that the catalyst-bearing thiolates are distributed statistically on the surface and that the ordered structure of the n-octanethiolate SAM can be retained during incorporation of the catalyst-bearing thiols using the place-exchange methodology.

Entities:  

Year:  2005        PMID: 15954778     DOI: 10.1021/ja0500714

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

1.  Target-triggered cascade assembly of a catalytic network as an artificial enzyme for highly efficient sensing.

Authors:  Lei Zhang; Fengjiao Ma; Jianping Lei; Jintong Liu; Huangxian Ju
Journal:  Chem Sci       Date:  2017-04-28       Impact factor: 9.825

2.  Redox-Responsive Nanocarrier for Controlled Release of Drugs in Inflammatory Skin Diseases.

Authors:  Keerthana Rajes; Karolina A Walker; Sabrina Hadam; Fatemeh Zabihi; Fiorenza Rancan; Annika Vogt; Rainer Haag
Journal:  Pharmaceutics       Date:  2020-12-29       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.